Search research articles
Contact Us
Filters
Showing results (71-80 of 266) with videos related to
Page
of 27
Sort By:
Cell Systems
|
July 2, 2018
IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to Immunotherapy
James C Chen, Rolando Perez-Lorenzo, Yvonne M Saenger, et al.
Cell Stem Cell
|
April 2, 2019
A Subset of TREM2<sup>+</sup> Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
Etienne C E Wang, Zhenpeng Dai, Anthony W Ferrante, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Charlene M Fares, Eliezer M Van Allen, Charles G Drake, et al.
World Journal of Urology
|
October 22, 2015
Immune checkpoint inhibitors: a new frontier in bladder cancer
Max Kates, Nikolai A Sopko, Hotaka Matsui, et al.
Plos Medicine
|
October 21, 2009
Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data
Takeshi Azuma, Gefeng Zhu, Haiying Xu, et al.
The Prostate
|
November 7, 2012
Strain-specific induction of experimental autoimmune prostatitis (EAP) in mice
Christopher M Jackson, Dallas B Flies, Claudio A Mosse, et al.
Immunotargets and Therapy
|
April 1, 2017
Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer
Mark Scholz, Sabrina Yep, Micah Chancey, et al.
Biotechniques
|
July 13, 2016
A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cells
Jelani C Zarif, James R Hernandez, James E Verdone, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment
James L Gulley, Ravi A Madan, Russell Pachynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function
Amy D H Doody, Joseph T Kovalchin, Marianne A Mihalyo, et al.
Page
of 27
Search research articles
Search
Showing results (71-80 of 266) with videos related to
Sort By:
Page
of 27
Cell Systems
|
July 2, 2018
IKZF1 Enhances Immune Infiltrate Recruitment in Solid Tumors and Susceptibility to Immunotherapy
James C Chen, Rolando Perez-Lorenzo, Yvonne M Saenger, et al.
Cell Stem Cell
|
April 2, 2019
A Subset of TREM2<sup>+</sup> Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
Etienne C E Wang, Zhenpeng Dai, Anthony W Ferrante, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 18, 2019
Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
Charlene M Fares, Eliezer M Van Allen, Charles G Drake, et al.
World Journal of Urology
|
October 22, 2015
Immune checkpoint inhibitors: a new frontier in bladder cancer
Max Kates, Nikolai A Sopko, Hotaka Matsui, et al.
Plos Medicine
|
October 21, 2009
Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data
Takeshi Azuma, Gefeng Zhu, Haiying Xu, et al.
The Prostate
|
November 7, 2012
Strain-specific induction of experimental autoimmune prostatitis (EAP) in mice
Christopher M Jackson, Dallas B Flies, Claudio A Mosse, et al.
Immunotargets and Therapy
|
April 1, 2017
Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer
Mark Scholz, Sabrina Yep, Micah Chancey, et al.
Biotechniques
|
July 13, 2016
A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cells
Jelani C Zarif, James R Hernandez, James E Verdone, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment
James L Gulley, Ravi A Madan, Russell Pachynski, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function
Amy D H Doody, Joseph T Kovalchin, Marianne A Mihalyo, et al.
Page
of 27